|
|
|
Press Releases
All Releases
 |
Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer
May 13, 2013
|
7.9 KB |
|
| |
ORANGEBURG, N.Y., May 13, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that Howard I. Zauberman has been named as Interim Chief Executive Officer, effective immediately.
Mr. Zauberm...
|
|
Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013
Apr 29, 2013
|
29.2 KB |
|
| |
ORANGEBURG, N.Y., April 29, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for its fourth quarter and fiscal year 2013, ended March 31, 2013.Fourth Quarter Fiscal Year 2...
|
|
Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results
Apr 23, 2013
|
7.6 KB |
|
| |
ORANGEBURG, N.Y., April 23, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the fourth quarter and full year fiscal 2013, ended Marc...
|
|
Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System
Mar 18, 2013
|
14.5 KB |
|
| |
ORANGEBURG, N.Y., March 18, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced the launch of the company's next-generation digital video processor. The 7000 Series Vision System®, an int...
|
|
Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors
Mar 12, 2013
|
14.0 KB |
|
| |
ORANGEBURG, N.Y., March 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that Dr. Cheryl Pegus, a renowned cardiologist and physician executive, has been appointed to the company's boar...
|
|
Vision-Sciences to Present at Canaccord Genuity Musculoskeletal Conference
Mar 6, 2013
|
7.1 KB |
|
| |
ORANGEBURG, N.Y., March 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that Cynthia Ansari, President and Chief Executive Officer, will present at 4:00 PM Central Standard Time at the ...
|
|
Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
Feb 7, 2013
|
6.7 KB |
|
| |
ORANGEBURG, N.Y., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that Cynthia Ansari, President and Chief Executive Officer, will participate in the Lazard Capital Markets 5th Ann...
|
|
Vision-Sciences Reports Net Sales of $4.0 Million for Third Quarter of Fiscal 2013
Jan 28, 2013
|
27.2 KB |
|
| |
ORANGEBURG, N.Y., Jan. 28, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for the three- and nine-month periods ended December 31, 2012, its third quarter and first nine...
|
|
Vision-Sciences Announces Release Date of Third Quarter of Fiscal 2013 Results
Jan 21, 2013
|
8.2 KB |
|
| |
ORANGEBURG, N.Y., Jan. 21, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the third quarter of fiscal 2013, ended December 31, 2012...
|
|
Vision-Sciences to Present at Lazard Capital Markets 9th Annual Healthcare Conference
Nov 8, 2012
|
7.2 KB |
|
| |
ORANGEBURG, N.Y., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced the Company will present at the Lazard Capital Markets 9th Annual Healthcare Conference to be held at the Pierre H...
|
|
Vision-Sciences Reports Net Sales of $3.7 Million for Second Quarter of Fiscal 2013
Nov 5, 2012
|
28.1 KB |
|
| |
ORANGEBURG, N.Y., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for the three- and six-month periods ended September 30, 2012, its second quarter and first half...
|
|
Vision-Sciences Reschedules Release Date of Second Quarter of Fiscal 2013 Results Due to Expected Severe Weather Conditions
Oct 29, 2012
|
12.8 KB |
|
| |
ORANGEBURG, N.Y., Oct. 29, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announces the postponement of today's release of its second quarter fiscal 2013 financial results and conference call, which was previously scheduled for Tuesday, October 30, 2012 at 8:30 a.m. Eastern Daylight Time (EDT), due to the expected severe weather condi...
|
|
Vision-Sciences Announces Release Date of Second Quarter of Fiscal 2013 Results
Oct 22, 2012
|
7.5 KB |
|
| |
ORANGEBURG, N.Y., Oct. 22, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the second quarter of fiscal 2013, ended September 30, 20...
|
|
Research Study Results Demonstrate Advantages of Vision-Sciences' EndoSheath(R) Technology for Bronchoscopy
Aug 1, 2012
|
9.4 KB |
|
| |
ORANGEBURG, N.Y., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced positive findings from a research study completed by the Department of Anesthesiology at Detroit Medical Center. T...
|
|
Vision-Sciences Reports Revenues of $3.4 Million for First Quarter 2013
Jul 26, 2012
|
23.5 KB |
|
| |
ORANGEBURG, N.Y., July 26, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for the three-month period ended June 30, 2012, its first quarter of fiscal 2013.First Quarter ...
|
|
Vision-Sciences Announces Release Date of First Quarter of Fiscal 2013 Results
Jul 23, 2012
|
15.5 KB |
|
| |
ORANGEBURG, N.Y., July 23, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the first quarter of fiscal 2013, ended June 30, 2012, be...
|
|
Vision-Sciences Announces Peer-Reviewed Publication of Clinical Study Utilizing Its EndoSheath(R) Technology to Diagnose Esophageal Disease
May 17, 2012
|
10.3 KB |
|
| |
ORANGEBURG, N.Y., May 17, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced positive findings from a 426-patient multi-center research study evaluating the feasibility, safety, acceptability...
|
|
Vision-Sciences Announces Record Revenue of $4.6 Million for Fourth Quarter and $16.7 Million for Full Year Fiscal 2012
May 15, 2012
|
27.0 KB |
|
| |
ORANGEBURG, N.Y., May 15, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for its fourth quarter and full year fiscal 2012, ended March 31, 2012.Fourth Quarter Fiscal Yea...
|
|
Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2012 Results
May 8, 2012
|
7.5 KB |
|
| |
ORANGEBURG, N.Y., May 8, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for its fourth quarter and full fiscal year ended March 31, 201...
|
|
Vision-Sciences Announces Purchase Agreement for up to $15 Million With Lincoln Park Capital Fund, LLC
Apr 27, 2012
|
9.0 KB |
|
| |
ORANGEBURG, N.Y., April 27, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that it has entered into a purchase agreement with Lincoln Park Capital Fund, LLC (LPC), a Chicago-based institu...
|
|
|
= add release to Briefcase |
| |
| |
|
|
|
